Teri Dahlman
Health Technology
Profile
Teri Dahlman worked as an Investor Relations Contact at Tetraphase Pharmaceuticals, Inc.
Former positions of Teri Dahlman
| Companies | Position | End |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Teri Dahlman
